Trials / Completed
CompletedNCT02994615
Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy
Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy: The Index of MicrovAscular Resistance (IMR)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Patients with hypertrophic cardiomyopathy are being compared to a control group. IMR will be assessed with a pressure wire. Clinical f/u at 3 months and 6 months and a 48 hour holter monitor.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2016-12-16
- Last updated
- 2020-09-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02994615. Inclusion in this directory is not an endorsement.